1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Optina (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

Optina (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

  • October 2014
  • -
  • GlobalData
  • -
  • 109 pages

Summary

Table of Contents

Search Inside

Optina (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

Summary

Macular Edema is a condition where fluid accumulates on the macula, leading to vision impairment or in severe cases even vision loss. The three main types of ME are diabetic macular edema (DME), and macular edema following either a central or branch retinal vein occlusion (ME-CRVO and ME-BRVO). Age-related macular degeneration (AMD) is a painless eye condition which leads to gradual, irreversible, loss of central vision, and is one of the leading causes of blindness among people aged 50 and over in the developed world. Currently the ME and AMD markets are dominated by the use of anti-VEGF monotherapy, however, in recent years, corticosteroid implants have been reaching the ME market which could challenge the stronghold these drugs have in this sector. The AMD market will see the arrival of the first therapies to treat dry AMD, fulfilling a huge unmet need in the management of this retinal disease, and these first-in-class therapies will strongly drive the market growth over the next ten years. The launch of wet AMD adjunctive therapies will also see a significant change in the treatment of AMD patients and have a positive impact on the market growth.

Optina is an orally-administered, ultra-low-dose capsule reformulation of the steroid danazol that is in Phase III of clinical development by Ampio Pharmaceuticals for the treatment of DME. An effective non-surgical drug treatment for DME is a high unmet need, and Optina is the only drug in late-phase development addressing this need.

Scope

- Overview of Macular Edema and Macular Degeneration, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on Optina including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for Optina for the top country from 2013 to 2023.
- Sales information covered for the US.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return.
- Stay ahead of the competition by understanding the changing competitive landscape for Macular Edema and Macular Degeneration.
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential.
- Make more informed business decisions from insightful and in-depth analysis of Optina performance.
- Obtain sales forecast for Optina from 2013-2023 in top country(the US).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Age-related macular degeneration (AMD) - Market Insights, Epidemiology and Market Forecast-2023

Age-related macular degeneration (AMD) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Age-related macular degeneration (AMD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Age-related ...

Dry eye disease- Market Insights, Epidemiology and Market Forecast-2023

Dry eye disease- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Dry eye disease - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Glaucoma  - Market Insights, Epidemiology and Market Forecast-2023

Glaucoma  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • March 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Glaucoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.